Baylor College of Medicine in Houston, Texas has announced plans to research the health benefits of cannabis products with Medterra CBD.
Baylor is one of America’s leading medical schools and hopes to deliver a scientific view of CBD’s capabilities as a health supplement and medical aid.
Dr Matthew Halpert, who will be leading the research team, said:
“This is an important study as we continue to see CBD surge in popularity, despite little scientific evidence to support patient claims of easing pain, reducing anxiety and helping with cognition and movement disorders”
The instructor of immunology added:
“With this study, we want to perform the necessary tests to verify CBD’s benefits, with the hope of determining, for instance, if the product reduces cartilage damage associated with arthritis”
The investigation has been deemed independent as the California-based manufacturers will have no input in the research.
Medterra CBD CEO and co-founder, Jay Hartenbach, said:
“As the industry continues to grow and more consumers become interested in the power of CBD, we have a responsibility to provide them with the best possible user experience, backed by true research.
“Through our work with Baylor we’ll be able to do just that.”
Baylor College of Medicine spends around $500 million on biomedical research each year and receives funding from the National Institutes of Health.